Trading Signals: BMY Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(Bristol-Myers Squibb Company)
| BMY latest price $60.0302 (-2.11%) ($59.6340 - $61.3732) on Thu. Dec. 14, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.13% (three month average) | RSI | 56 | Latest Price | $60.0302(-2.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BMY advances 0.1% a day on average for past five trading days. | Weekly Trend | BMY advances 0.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BMY advance at 0% a week (0% probability) XLV(57%) VYM(48%) SPLV(47%) IVE(46%) IWD(46%) | Factors Impacting BMY price | BMY will decline at least -0.565% in a week (0% probabilities). VIXM(-18%) TLT(-13%) UUP(-8%) IGOV(-5%) SHY(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.565% (StdDev 1.13%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
Resistance Level | $60.07 | 5 Day Moving Average | $60.74(-1.17%) | 10 Day Moving Average | $60.38(-0.58%) | 20 Day Moving Average | $60.07(-0.07%) | To recent high | -4.9% | To recent low | 3.7% | Market Cap | $135.304b | | | | Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. |